Article

Accommodating, multifocal IOLs make effective combination, study finds

Results of a retrospective study show good visual acuity outcomes at near, intermediate, and distance, and high rates of satisfaction can be achieved using a strategy combining an accommodating IOL (crystalens, eyeonics) in one eye with the apodized diffractive multifocal IOL (AcrySof ReSTOR, Alcon Laboratories) in the other eye in patients undergoing cataract surgery or a clear lens exchange procedure.

Key Points

San Diego-Implanting an accommodating IOL (AT-45 crystalens, eyeonics) and an apodized diffractive multifocal IOL (AcrySof ReSTOR, Alcon Laboratories) in fellow eyes may be an effective approach for expanding the focal range of vision in patients undergoing cataract surgery or a clear lens exchange procedure, said Randy T. Jackson, MD, here at the annual meeting of the American Society of Cataract and Refractive Surgery.

"We also found no significant difference between eyes with respect to visual symptoms, including blur, halo, glare, ghosting, and night or day driving. That was somewhat surprising since, overall, the patients favored the quality of vision in the eye with the accommodating IOL," Dr. Jackson said.

All patients in the study had at least 1 month of follow-up and received the accommodating IOL in the dominant eye and the clear, one-piece diffractive IOL in the non-dominant eye. Target refraction was –0.25 D for the eye with the accommodating lens and plano for the eye with the diffractive lens.

Preoperatively, best corrected visual acuity ranged from 20/15 to 20/60, spherical equivalent was between –9.00 D and +3.50 D, and mean astigmatism was just under 1.0 D. Maximum follow-up was approximately 13.5 months, with an average of approximately 4 months.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.